Elastrin Therapeutics

Elastrin Therapeutics focuses on developing innovative treatments for cardiovascular diseases. Their research centers around the role of elastin, a protein that provides elasticity and structure to tissues throughout the body. Elastrin Therapeutics has developed groundbreaking technology DESTiNED, a proprietary platform that uses nanoparticles to target damaged elastin fibers. This technology enables them to selectively deliver drugs to areas where elastin has been degraded, such as the artery walls and lungs. The company's primary focus is on reversing cardiovascular calcification, a condition that can lead to heart valve stenosis and arterial stiffening. Their treatments aim to restore the elasticity of these tissues, improving blood flow and reducing the risk of heart disease.

Jobs: